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What does quality of life (QOL) mean? What does it
denote? What parameters can be used to measure QOL?
These must be the most telling and repetitive questions
during the last decades. We all want answers to problems
we have encountered. From such answers we synthesize
new questions and further answers, leading to innovation
and change.
With respect to the first question, QOL is a complex
and multidimensional concept that is difficult to define
and measure1-3. Consequently, various conceptual and
operational definitions have been used in QOL4,5. Kohli
et al6 in their article in this issue have collected several
definitions. QOL is a term that is popularly used to
convey an overall sense of well being and includes
aspects such as happiness and satisfaction with life as a
whole. World Health Organisation has defined QOL as
‘individuals’ perceptions of their position in life in the
context of the culture and value systems in which they
live and in relation to their goals, standards, expectations
and concerns”7.
Among patients, especially those who have chronic,
incurable diseases, health-related quality of life
(HRQOL) may be the most important outcome to be
considered when assessing treatment effectiveness.
Because the patient is the best source of information
about his or her HRQOL, many practical tools have been
developed that rely on patient self-ratings. The HRQOL
has increasingly gained importance as an outcome
measure in health care8,9, especially as regard
interventions for patients with various chronic diseases10.
The human immunodeficiency virus type 1 (HIV)
infection induces a wide array of immunological
alterations resulting in the progressive development of
opportunistic infections and malignancy, which results
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in AIDS. The HIV infection is also associated with
different psychological and neuropsychiatric disorders.
Today, there is no cure against HIV infection.
Therapeutic management of patient is concentrated more
on delaying the suppression of the immune system and
on controlling and preventing opportunistic infections
and cancer.
Recent estimates by the joint United Nations
Programme on HIV/AIDS and the World Health
Organization suggest that of the 34.3 million people
currently infected with HIV, 95 per cent live in sub
Saharan Africa and the developing countries of Asia
and Latin America. With nearly 17,000 infections
occurring every day, the estimate for the end of the
twentieth century is more than 40 million infected
people. Unless a cure is found or life-prolonging
therapy can be made more widely available, the
majority of people living with HIV or AIDS will
continue to suffer with the disease, with serious impact
on their quality of life. For this reason, development
and implementation of a reliable and valid cross-
cultural quality of life measure is necessary that can
be used not only to asses the physical and medical
needs of HIV/AIDS people, but also their
psychological, social, environmental and spiritual areas
of life11. This is particularly pertinent for use with those
living in developing countries where medical care is
currently unavailable and social support is at a
minimum.
Assessment of QOL in individuals living with HIV/
AIDS is becoming crucial to research and evidence-
based practice in this area. QOL is currently considered
essential for clinical trials in HIV infection, as
commonly used end-points (CD4 level, viral load,
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opportunistic diseases) are inadequate to catch the
complexity of treatment outcomes. The World Health
Organization has developed a standardized set of
instruments to asses subjective QOL in different medical
conditions, including HIV infection. Starace et al12, have
reported evidence for the acceptability, reliability and
validity of the Italian version of the WHOQOL-HIV.
Recently an analysis of the WHOQOL HIV field test
instrument was performed in patients from seven
culturally diverse centres (Australia, Brazil, Italy,
Thailand, Ukraine and two centres in India: Bangalore
and New Delhi)13.
Kohli et al6, described the dimension of QOL among
HIV infected patients to study their relationship with
socio-demographic characteristics and the stages of
disease progression and to examine changes in QOL
over time. They modified the medical outcome study
(MOS) core instrument to suit the Indian cultural setting
and used. Of the 62 questions contained in the core
instrument, 20 were selected for inclusion in the
modified instrument. The language was modified and
response categories were reduced in most of these
questions. Some questions were clubbed so that they
can be applicable to both sexes. One question resulted
from the combination of two so that the instrument does
not become very long, whereas another one was split
for the clarity of responses. Because some of the
activities of daily routine were different in Indian
population, the authors had modified some questions
with relevant activities.
In addition, different questions were regrouped under
different domains according to previous studies14-16 about
the QOL of HIV positive individuals. Besides, opinion
of experts in social science research, physicians working
in the field of HIV/AIDS, and HIV patients was taken
into consideration in order to modify items suitably for
Indian cultural setting. The authors considered that
domains on food and appetite and sexual activities would
be relevant and in consequence they were added to the
instrument. Finally, items on stigma and discrimination
were also incorporated.
The modified MOS QOL instrument displayed items
on QOL related to health among infected persons. It
consisted of 29 structured questions in 10 domains:
physical health, work and earnings, daily routine, social
activities, cognitive functions feelings and emotions,
pain, food and appetite, sleep and sexual life.
The modified MOS QOL instrument used in this
study was found to be appropriate and suitable for
assessing the quality of life in HIV infected person in
India. The scale was reliable with Cronbach alpha value
more than 0.70 for all the domains. The validity of the
instrument was also supported by the observed
relationship between QOL scores and CD4 counts and
stages of clinical disease. Besides, the HRQOL scores
changed over a period of time as was evident from the
follow up observations. The association between the
different demographic and clinical parameters and the
QOL scores showed that there existed differences
between men and women with respect to QOL scores
with women having significantly lower scores in many
domains than men. These results agree with those
obtained in previous studies performed in two centres
in India (Bangalore and New Delhi)13 and with the ones
observed by other investigators17-19.
In conclusion, although considerable work has been
done in this field, little has been done in clinical setting
in India for the purposes of quality improvement. The
modified medical outcome study (MOS) instrument for
QOL assessment in HIV infected individuals proposed
by Kohli et al6 undoubtedly provides a new set of
opportunities for studying the problem of QOL
assessment in HIV individuals in India.
The modified medical outcome study (MOS)
instrument6 is a valid measure of quality of life in the
HIV infected population in India and is therefore likely
to be useful in future clinical trials in the region. These
findings suggest a need to incorporate new methods for
improving the knowledge of chronic pathologies. This
work will eventually have an impact in clinical research
in India and will help medical community in further
investigations on this topic.
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